Nav: Home

Study reveals elevated cancer risk in children with birth defects

June 25, 2019

Childhood cancer is a rare occurrence in the overall population but may be somewhat more frequent in children born with birth defects. To better understand the link between cancer risk and birth defects, a collaborative team of scientists led by Baylor College of Medicine has assembled the largest study to date to evaluate cancer risk in children with birth defects. The study appears in JAMA Oncology.

"While cancer risk in children with certain chromosomal defects like Down syndrome is well established, much less is known for children with birth defects where there is no known genetic cause, sometimes called non-chromosomal defects," said Dr. Philip Lupo, associate professor of pediatrics - hematology oncology and member of the Dan L Duncan Comprehensive Cancer Center at Baylor. "Non-chromosomal defects, as a group, affect more children, but one of the primary challenges of understanding risk among these children is that limited sample sizes make studying specific defects, like spina bifida, more difficult."

The research team gathered data from birth, birth defect and cancer registries across Texas, Arkansas, Michigan and North Carolina to generate a birth cohort of more than 10 million children born between 1992 and 2013. The investigators looked at diagnoses of cancer until 18 years of age to determine differences in cancer risk between those with and without birth defects.

Researchers found that, compared to children without any birth defect, children with chromosomal defects were almost 12 times more likely to develop cancer, while children with non-chromosomal defects were 2.5 times more likely to develop cancer. Additionally, children with more than one non-chromosomal defect had a corresponding increase in cancer risk.

"Our two key objectives in this study were to identify children who are at an increased risk for cancer, because subsets of these children may one day benefit from screening and better clinical management, and to uncover clues as to why cancer occurs more frequently in this population," said Dr. Jeremy Schraw, postdoctoral associate in the Section of Epidemiology and Population Sciences at Baylor. "These findings solidify our understanding of cancer risk in these children and show that we need additional research in this area."

Cancer types that were more frequent in children with non-chromosomal defects included hepatoblastoma and neuroblastoma.

While these findings identify specific, strong associations between birth defects and cancer, Schraw said that it is important to remember that both birth defects and cancer are still rare occurrences.

"This study is important in that it is the largest and most informative of its kind. The large sample size allowed us to evaluate cancer risk in children with both chromosomal versus non-chromosomal defects and revealed links between specific cancers and specific birth defects. These data can also help us to study and understand differences in outcomes down the road for children with cancer," said Dr. Sharon Plon, professor of pediatrics - oncology and molecular and human genetics and co-director of the Pediatric Cancer Program in the Dan L Duncan Comprehensive Cancer Center at Baylor.

"In the future, we hope to identify the specific genes behind these associations and systematically research what happens from the time of birth to the time of cancer onset to also understand if environmental factors may be contributing to cancer development," Lupo said. "This study provides new understanding about biology and the mechanisms that may lead to these complex outcomes in this population."
-end-
This study was supported by the Cancer Prevention and Research Institute of Texas, Alex's Lemonade Stand Foundation, the National Cancer Institute, and Arkansas Biosciences Institute. For a full list of contributors, visit the journal website.

Baylor College of Medicine

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#SB2 2019 Science Birthday Minisode: Mary Golda Ross
Our second annual Science Birthday is here, and this year we celebrate the wonderful Mary Golda Ross, born 9 August 1908. She died in 2008 at age 99, but left a lasting mark on the science of rocketry and space exploration as an early woman in engineering, and one of the first Native Americans in engineering. Join Rachelle and Bethany for this very special birthday minisode celebrating Mary and her achievements. Thanks to our Patreons who make this show possible! Read more about Mary G. Ross: Interview with Mary Ross on Lash Publications International, by Laurel Sheppard Meet Mary Golda...